KEAP1 and non-small cell lung carcinoma: The aim of this study is to investigate the protein expression levels of Keap1 in non-small cell lung cancer (NSCLC) patients as well as to correlate its expression with the response rate (RR), progression-free survival (PFS), and overall survival (OS) of patients treated with platinum-based first-line chemotherapy.